SEC Form 4 reporting owner

Krainer Adrian R.

Krainer Adrian R. has filed 3 Form 4 transactions reported between March 2, 2026 and June 3, 2026, as a reporting owner of Stoke Therapeutics, Inc..

Name as filed: Krainer Adrian R.

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$1.6M
2 lines
Companies
1
with Form 4 filings
Latest transaction
Jun 3, 2026
transaction date

Roles and reported holdings

  • STOKStoke Therapeutics, Inc.
    Mar 2, 2026 – Jun 3, 2026

    Reporting owner

    Held directly283,302 sh as of Mar 10, 2026 · Form 4

    24 months: $1.6M sold

Transaction history

All 3 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Jun 3, 2026STOKGrant or awardCode A · direct17,786—Form 4
Mar 10, 2026STOKOpen-market saleCode S · direct33,243$1.3M@ $39.74Form 4
Mar 2, 2026STOKOpen-market saleCode S · direct7,229$287K@ $39.66Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.